Search - tctmd.com

Displaying 281 - 300 of 324

Sort: Relevancy | Date

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

News Daily News

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Michael O'Riordan

September 27, 2017

As Percutaneous Mitral Valve Techniques Advance, Questions Turn to Combinations, Staging

News Conference News PCR London Valves 2017

As Percutaneous Mitral Valve Techniques Advance, Questions Turn to Combinations, Staging

September 26, 2017

Frail Patients Benefit From MitraClip, With Gains in Function and Quality of Life

News Daily News

Frail Patients Benefit From MitraClip, With Gains in Function and Quality of Life

Michael O'Riordan

September 18, 2017

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

News Conference News TVT 2017

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Michael O'Riordan

June 20, 2017

MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns

News Conference News ACC 2017

MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns

March 27, 2017

Live From Washington: ACC 2017, Day One

News Conference News ACC 2017

Live From Washington: ACC 2017, Day One

March 17, 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

News Conference News ACC 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

March 17, 2017

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

News Daily News

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

March 15, 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

March 10, 2017

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

News Conference News ISET 2017

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

February 06, 2017

News Daily News

Readmissions After TAVR Common, With Most Due to Noncardiac Reasons

January 06, 2017

News Daily News

Leaflet Thickening, Valve Durability After Balloon-Expandable TAVR: Studies Offer New Insights

December 26, 2016

News Conference News AHA 2016

“Huge Shift” Favoring Interventions in Aortic Stenosis Care May Still Omit Many Elderly Patients

Yael L. Maxwell

November 21, 2016

News Daily News

At 3 Years Post-TAVR, Valve Performance Holds Steady and Most Mortality Is Noncardiac: FRANCE 2 Registry

October 04, 2016

News Conference News PCR London Valves 2016

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

September 20, 2016

News Daily News

Infective Endocarditis After TAVR Linked to Diabetes, Residual Aortic Regurgitation in Large Registry

Yael L. Maxwell

September 14, 2016

News Daily News

Aortic Complications Spike for Women During Pregnancy and Shortly After Giving Birth

August 09, 2016

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

News Conference News TVT 2016

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

Michael O'Riordan

June 20, 2016

News Conference News EuroPCR 2016

Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests

Yael L. Maxwell

May 20, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.